+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intellectual Property Market Research Reports

Vaccine Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Vaccine Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 400 Pages
  • Global
From
Antibody Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Antibody Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 750 Pages
  • Global
From
Drug Delivery Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Drug Delivery Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 750 Pages
  • Global
From
Infectious Vaccine Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Infectious Vaccine Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 300 Pages
  • Global
From
Antibiotic Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Antibiotic Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 100 Pages
  • Global
From
Regenerative Medicine Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Regenerative Medicine Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 700 Pages
  • Global
From
Microbiome Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Microbiome Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 200 Pages
  • Global
From
Companion Diagnostic Collaboration and Licensing Deals 2010-2024 - Product Thumbnail Image

Companion Diagnostic Collaboration and Licensing Deals 2010-2024

  • Report
  • November 2024
  • 300 Pages
  • Global
From
Diagnostic Collaboration and Licensing Deals 2020-2024 - Product Thumbnail Image

Diagnostic Collaboration and Licensing Deals 2020-2024

  • Report
  • November 2024
  • 750 Pages
  • Global
From
From
Monoclonal Antibody Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Monoclonal Antibody Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 350 Pages
  • Global
From
Diagnostic Imaging Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Diagnostic Imaging Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 350 Pages
  • Global
From
From
Bioinformatics Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Bioinformatics Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
Cancer Diagnostic Collaboration and Licensing Deals 2018-2024 - Product Thumbnail Image

Cancer Diagnostic Collaboration and Licensing Deals 2018-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
Gene Therapy Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Gene Therapy Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
Medical Device Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Medical Device Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
Loading Indicator

The Intellectual Property (IP) market is a sector of the economy that deals with the creation, protection, and commercialization of intangible assets such as patents, trademarks, copyrights, and trade secrets. IP is a valuable asset for businesses, as it can be used to protect their products and services from competitors. Companies in the IP market provide services such as patent filing, trademark registration, copyright protection, and IP litigation. The IP market is composed of a variety of companies, including law firms, patent and trademark offices, IP consulting firms, and IP brokers. These companies provide services such as patent searches, patent drafting, trademark searches, trademark registration, copyright registration, and IP litigation. Additionally, some companies specialize in IP valuation, IP licensing, and IP portfolio management. Notable companies in the IP market include Baker & McKenzie, Finnegan, Fish & Richardson, and Kilpatrick Townsend. Other companies include Brinks Gilson & Lione, Cantor Colburn, and Knobbe Martens. Show Less Read more